Related Experiment Video
Updated: Oct 20, 2025

Author Spotlight: Developing Novel Anticancer Therapeutics Targeting the DNA Damage Response
Published on: June 14, 2024
Mechanism, cellular functions and cancer roles of polymerase-theta-mediated DNA end joining
Dale A Ramsden1,2,3, Juan Carvajal-Garcia4, Gaorav P Gupta5,6,7,8
1Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. dale_ramsden@med.unc.edu.
Abstract:
Cellular pathways that repair chromosomal double-strand breaks (DSBs) have pivotal roles in cell growth, development and cancer. These DSB repair pathways have been the target of intensive investigation, but one pathway - alternative end joining (a-EJ) - has long resisted elucidation. In this Review, we highlight recent progress in our understanding of a-EJ, especially the assignment of DNA polymerase theta (Polθ) as the predominant mediator of a-EJ in most eukaryotes, and discuss a potential molecular mechanism by which Polθ-mediated end joining (TMEJ) occurs. We address possible cellular functions of TMEJ in resolving DSBs that are refractory to repair by non-homologous end joining (NHEJ), DSBs generated following replication fork collapse and DSBs present owing to stalling of repair by homologous recombination. We also discuss how these context-dependent cellular roles explain how TMEJ can both protect against and cause genome instability, and the emerging potential of Polθ as a therapeutic target in cancer.
Insights
Alternative end joining (a-EJ), mediated by DNA polymerase theta (Polθ), repairs challenging DNA double-strand breaks (DSBs). This pathway, termed Polθ-mediated end joining (TMEJ), has implications for genome stability and cancer therapy.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Cellular pathways repairing DNA double-strand breaks (DSBs) are crucial for cell growth, development, and cancer.
- Alternative end joining (a-EJ), a DSB repair pathway, has remained poorly understood.
- Non-homologous end joining (NHEJ) is a primary DSB repair mechanism, but alternative pathways exist.
Purpose of the Study:
- To review recent advancements in understanding the alternative end joining (a-EJ) pathway.
- To highlight the role of DNA polymerase theta (Polθ) as the primary mediator of a-EJ.
- To discuss the molecular mechanisms and cellular functions of Polθ-mediated end joining (TMEJ).
Main Methods:
- Literature review of recent studies on a-EJ and Polθ.
- Analysis of proposed molecular mechanisms for TMEJ.
- Discussion of cellular contexts where TMEJ operates.
Main Results:
- DNA polymerase theta (Polθ) is identified as the predominant mediator of a-EJ in most eukaryotes.
- A potential molecular mechanism for Polθ-mediated end joining (TMEJ) is proposed.
- TMEJ resolves various types of DSBs, including those resistant to NHEJ, those from replication fork collapse, and those from stalled homologous recombination.
Conclusions:
- TMEJ plays context-dependent roles in resolving difficult DSBs.
- TMEJ can contribute to both genome stability and instability.
- Polθ represents a potential therapeutic target for cancer treatment.
More Related Videos
Related Concept Videos
Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
Proofreading
Errors During Replication are Corrected by the DNA Polymerase...
DNA Damage can Stall the Cell Cycle
Fixing Double-strand Breaks
Homologous Recombination
DNA Helicases

